The "NewCo" model, where a new company is formed around assets licensed from an existing firm, is a key strategy for Western investors to access a deep well of innovation from Chinese companies like Heisco, which are largely unknown in the West but possess broad, innovative pipelines.

Meta's acquisition of Manus, a Chinese-founded startup that moved to Singapore, is being scrutinized by Beijing. This shows that simply changing legal domicile is not enough to escape China's control over deals involving its domestic technology, data, or talent, setting a precedent for future cross-border M&A.

The most significant sanctions loophole isn't physical chip smuggling but 'compute smuggling.' Chinese firms establish shell companies to build and operate data centers in neutral countries like Malaysia. They then access this cutting-edge compute power remotely, completely bypassing physical import restrictions on advanced hardware.

Meta's $2.5B acquisition of Butterfly Effect shows a playbook for acquiring Chinese-origin tech. By relocating to a neutral country like Singapore, the company becomes palatable for US investment and acquisition, navigating geopolitical regulations and PR backlash, effectively getting "into the democracy bucket."

Contrary to the popular narrative of a top-down, state-directed effort, much of China's absorption of Western technology is driven by the self-interest of individual companies. Both private and state-owned enterprises proactively acquire innovative foreign firms to transfer technology back home, suggesting a decentralized, market-driven process.

Contrary to the popular narrative of a monolithic, state-led effort, much of China's technological acquisition was driven by a bottom-up rush. Individual private and state-owned enterprises acted in their own self-interest, proactively seeking out and investing in foreign innovation to bring back home, independent of a central directive.

Beyond just pharma, China is engaging in a 'salami slicing' strategy to take over the foundational infrastructure of the U.S. biotech economy. This slow, incremental acquisition of manufacturing and research capabilities mirrors its successful long-term strategy for dominating sectors like rare earths.

A groundbreaking study reveals a hidden strategy behind China's tech ascent. Chinese firms used subsidiaries in tax havens like the Cayman Islands to secretly acquire foreign companies, amassing $3.3 trillion in assets. The primary target was pre-patent intellectual property, which was then transferred and patented back in China.

Prominent investor Keith Rabois claims that payments company Airwallex, despite its Singapore HQ, has significant operations and legal obligations in China. He alleges this structure requires them to assist with CCP espionage by providing sensitive financial data from US customers, including AI labs and defense contractors.